调胃和中汤治疗慢性胃炎的网络药理学分析
Network Pharmacological Analysis of Tiaoweihezhong Decoction in Treating Chronic Gastritis
DOI: 10.12677/tcm.2024.1310381, PDF,    科研立项经费支持
作者: 刘 娜:广西中医药大学研究生院,广西 南宁;苏颖洁*:广西医科大学附属肿瘤医院消化内科,广西 南宁
关键词: 网络药理学慢性胃炎调胃和中汤作用机制Network Pharmacology Chronic Gastritis Tiaoweihezhong Decoction Action Mechanism
摘要: 目的:应用网络药理学分析具有抗炎功效的调胃和中汤治疗慢性胃炎的作用机制。方法:使用中医药系统药理学数据库与分析平台(TCMSP)检索调胃和中汤中单味药活性成分与作用靶点,在相关数据库中检索慢性胃炎的疾病靶点。将预测的药物与疾病交集靶点导入STRING数据库进行分析并搭建蛋白互作网络(PPI)。基于Metascape数据库进行GO功能与KEGG通路富集分析,并绘制相应结果图,探究其作用机制。结果:检索后共获得活性成分对应靶点332个,其中作用于慢性胃炎的交集靶点有112个;蛋白互作网络关键靶点主要为AKT1、IL-6、TNF、TP53、IL-Iβ、JUN等。GO富集分析得到富集的生物过程集中在对外来生物刺激、氧化应激及激素的反应,对细胞增殖、迁移的调节,对凋亡信号通路的调控等方面;KEGG通路富集分析结果显示,调胃和中汤可能通过介导AGE-RAGE、PI3K-AKT、JAK-STAT和NF-κB等信号通路发挥疗效。结论:该研究结果初步揭示了调胃和中汤通过多成分、多靶点、多通路治疗慢性胃炎,但尚有不足之处,需要后期实验研究进一步验证。
Abstract: Objective: The mechanism of Tiaoweihezhong Decoction with anti-inflammatory effect on chronic gastritis was studied by using network pharmacology. Methods: The TCMSP platform was used to search the single ingredient and target of Tiaoweihezhong Decoction, and the disease target of chronic gastritis was searched in databases. The predicted intersection targets of drugs and diseases were imported into the STRING database for analysis and the protein interaction network was constructed. The enrichment analysis of GO function and KEGG pathway was carried out based on Metascape database, and corresponding result diagrams were drawn according to the results. The “target-pathway” network was constructed by Cytoscape 3.7.2 to explore its mechanism. Results: A total of 332 targets corresponding to active ingredients were obtained, of which 112 were intersections for chronic gastritis; The key targets of the protein interaction network were AKT1, IL-6, TNF, TP53, IL-Iβ, JUN, etc. The GO pathway enrichment analysis showed that the enriched biological processes included the response to foreign biological stimuli, oxidative stress and hormones, the regulation of cell proliferation and migration, and the regulation of apoptosis signaling pathways. The results of KEGG pathway enrichment analysis showed that Tiaoweihezhong Decoction may exert therapeutic effect by acting on AGE-RAGE, PI3K-Akt, JAK-STAT and NF-κB signaling pathways, etc. Conclusion: The results of this study preliminarily revealed that Tiaoweihezhong Decoction can treat chronic gastritis through multi-component, multi-target and multi-pathway. But there are still many shortcomings, which need to be verified by later experimental studies.
文章引用:刘娜, 苏颖洁. 调胃和中汤治疗慢性胃炎的网络药理学分析[J]. 中医学, 2024, 13(10): 2565-2575. https://doi.org/10.12677/tcm.2024.1310381

参考文献

[1] 中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年, 上海) [J]. 中华消化杂志, 2023, 43(3): 145-175.
[2] Lim, N.R. and Chung, W.C. (2023) Helicobacter pylori-Associated Chronic Atrophic Gastritis and Progression of Gastric Carcinogenesis. The Korean Journal of Gastroenterology, 82, 171-179. [Google Scholar] [CrossRef] [PubMed]
[3] Yang, H. and Hu, B. (2022) Immunological Perspective: Helicobacter Pylori Infection and Gastritis. Mediators of Inflammation, 2022, Article ID: 2944156. [Google Scholar] [CrossRef] [PubMed]
[4] 林采玥, 林惠, 冼思彤, 等. 壮医药线点灸联合壮医针刺治疗脾胃虚寒型胃脘痛(慢性胃炎)临床观察[J]. 广西中医药, 2024, 47(2): 39-43.
[5] 蔡文威, 秦祖杰, 韦雨露, 等. 从壮医三气同步理论谈慢性胃炎的病机与治疗[J]. 中医药导报, 2021, 27(8): 211-214.
[6] 林辰, 黄汉儒, 薛丽飞. 论壮医学的基本特点及核心理论[J]. 中国中医基础医学杂志, 2012, 18(11): 1205-1206.
[7] 宋宁. 壮医道路理论初探[J]. 中国中医基础医学杂志, 2011, 17(5): 490-492.
[8] 覃正萍, 斯韬, 黄萍, 等. 三道两路理论探析鼻咽癌防治[J]. 光明中医, 2023, 38(14): 2714-2717.
[9] 刘娜, 林艺, 韦梅, 等. 基于网络药理学探讨龙葵-半枝莲药对治疗胃癌的作用机制[J]. 中医临床研究, 2024, 16(12): 1-6.
[10] Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A.H., Tanaseichuk, O., et al. (2019) Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets. Nature Communications, 10, Article No. 1523. [Google Scholar] [CrossRef] [PubMed]
[11] 谭丽春, 李征, 杨继勇, 等. 石斛属植物的化学成分及药理作用研究进展[J]. 山东化工, 2023, 52(1): 74-76.
[12] 张慧茹, 张婷婷, 许枬, 等. 基于NMR指导的六神曲成分研究[J]. 中草药, 2019, 50(16): 3764-3768.
[13] 李虹霞, 朱月健, 尹磊, 等. 六神曲化学成分及抗氧化活性研究[J]. 中成药, 2023, 45(3): 788-794.
[14] 刘书豪, 王有宪, 邵仲柏, 等. 海螵蛸提取物活性成分分析及止血机制[J]. 中成药, 2022, 44(10): 3366-3368.
[15] 周方方, 陶鑫, 金维维. 基于网络药理学探讨金鸡胶囊治疗盆腔炎的分子机制研究[J]. 河南医学高等专科学校学报, 2023, 35(4): 355-360.
[16] 张长军, 陶庆春. 慢性胃炎患者中医证型与相关实验室指标的关系[J]. 北京中医药, 2022, 41(6): 685-688.
[17] 肖明兴. 天然产物Przewalskin B的全合成研究[D]: [博士学位论文]. 兰州: 兰州大学, 2014.
[18] McKenna, M., Balasuriya, N., Zhong, S., Li, S.S. and O’Donoghue, P. (2021) Phospho-Form Specific Substrates of Protein Kinase B (AKT1). Frontiers in Bioengineering and Biotechnology, 8, Article 619252. [Google Scholar] [CrossRef] [PubMed]
[19] Xue, J., Shi, Z., Zou, J. and Li, X. (2017) Inhibition of PI3K/Akt/mTOR Signaling Pathway Promotes Autophagy of Articular Chondrocytes and Attenuates Inflammatory Response in Rats with Osteoarthritis. Biomedicine & Pharmacotherapy, 89, 1252-1261. [Google Scholar] [CrossRef] [PubMed]
[20] Malysch, T., Reinhold, J.M., Becker, C.A., Schmidt-Bleek, K. and Kleber, C. (2022) In Vivo Immunomodulation of IL6 Signaling in a Murine Multiple Trauma Model. Immunologic Research, 71, 164-172. [Google Scholar] [CrossRef] [PubMed]
[21] Kang, S., Narazaki, M., Metwally, H. and Kishimoto, T. (2020) Historical Overview of the Interleukin-6 Family Cytokine. Journal of Experimental Medicine, 217, e20190347. [Google Scholar] [CrossRef] [PubMed]
[22] Horiuchi, T., Mitoma, H., Harashima, S., Tsukamoto, H. and Shimoda, T. (2010) Transmembrane TNF-α: Structure, Function and Interaction with Anti-TNF Agents. Rheumatology, 49, 1215-1228. [Google Scholar] [CrossRef] [PubMed]
[23] 杨辉, 李小芹, 于静, 等. IL-6、IL-8、TNF-α在慢性胃炎患儿血清变化意义研究[J]. 中国医学工程, 2021, 29(1): 48-50.
[24] 危柳柳, 赖月亮, 朱方擎, 等. miR-21通过Bcl-2和P53对早期胃癌病理形态学的影响[J]. 中国老年学杂志, 2022, 42(14): 3545-3548.
[25] 甘泽隆, 谢光波, 谢丽源. 基于网络药理学及分子对接技术探究猴头菇治疗慢性胃炎的潜在作用机制[J]. 菌物学报, 2023, 42(12): 2422-2441.
[26] El-Omar, E.M. (2001) The Importance of Interleukin 1β in Helicobacter pylori Associated Disease. Gut, 48, 743-747. [Google Scholar] [CrossRef] [PubMed]
[27] 刘露, 刘占奎, 吴雪, 等. 狼毒大戟调节AGE-RAGE信号通路对肝硬化大鼠炎症反应和纤维化的影响[J]. 中国老年学杂志, 2023, 43(15): 3800-3804.
[28] Prasad, K. and Bhanumathy, K.K. (2020) AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment. International Journal of Angiology, 29, 156-167. [Google Scholar] [CrossRef] [PubMed]
[29] Fattahi, S., Amjadi-Moheb, F., Tabaripour, R., Ashrafi, G.H. and Akhavan-Niaki, H. (2020) PI3K/AKT/mTOR Signaling in Gastric Cancer: Epigenetics and Beyond. Life Sciences, 262, Article ID: 118513. [Google Scholar] [CrossRef] [PubMed]
[30] 田琳, 黄铭涵, 李思汉, 林平, 郑榕, 施婧瑶. 从JAK1/STAT3信号通路探讨复方胃炎合剂抑制慢性萎缩性胃炎进展的分子机制[J]. 实用中医内科杂志, 2021, 35(9): 37-40, 154.